RNA Oligonucleotide Synthesis Service - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510243372

Publication Date:

October 2, 2024

Pages:

125

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for RNA Oligonucleotide Synthesis Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for RNA Oligonucleotide Synthesis Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Oligonucleotide Synthesis Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for RNA Oligonucleotide Synthesis Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of RNA Oligonucleotide Synthesis Service include GenScript, OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs and Bio Basic, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for RNA Oligonucleotide Synthesis Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RNA Oligonucleotide Synthesis Service by region & country, by Type, and by Application.
The RNA Oligonucleotide Synthesis Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Oligonucleotide Synthesis Service.
麻豆原创 Segmentation
By Company
GenScript
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems
Segment by Type:
Standard Oligonucleotides
Micro-Oligonucleotides
Large-scale Oligonucleotides
Degenerate Primers
Long Oligos Synthesis
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RNA Oligonucleotide Synthesis Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RNA Oligonucleotide Synthesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RNA Oligonucleotide Synthesis Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 RNA Oligonucleotide Synthesis Service Product Introduction
1.2 Global RNA Oligonucleotide Synthesis Service 麻豆原创 Size Forecast
1.3 RNA Oligonucleotide Synthesis Service 麻豆原创 Trends & Drivers
1.3.1 RNA Oligonucleotide Synthesis Service Industry Trends
1.3.2 RNA Oligonucleotide Synthesis Service 麻豆原创 Drivers & Opportunity
1.3.3 RNA Oligonucleotide Synthesis Service 麻豆原创 Challenges
1.3.4 RNA Oligonucleotide Synthesis Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global RNA Oligonucleotide Synthesis Service Players Revenue Ranking (2023)
2.2 Global RNA Oligonucleotide Synthesis Service Revenue by Company (2019-2024)
2.3 Key Companies RNA Oligonucleotide Synthesis Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies RNA Oligonucleotide Synthesis Service Product Offered
2.5 Key Companies Time to Begin Mass Production of RNA Oligonucleotide Synthesis Service
2.6 RNA Oligonucleotide Synthesis Service 麻豆原创 Competitive Analysis
2.6.1 RNA Oligonucleotide Synthesis Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by RNA Oligonucleotide Synthesis Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Oligonucleotide Synthesis Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Standard Oligonucleotides
3.1.2 Micro-Oligonucleotides
3.1.3 Large-scale Oligonucleotides
3.1.4 Degenerate Primers
3.1.5 Long Oligos Synthesis
3.2 Global RNA Oligonucleotide Synthesis Service Sales Value by Type
3.2.1 Global RNA Oligonucleotide Synthesis Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global RNA Oligonucleotide Synthesis Service Sales Value, by Type (2019-2030)
3.2.3 Global RNA Oligonucleotide Synthesis Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Commercial
4.1.2 Academic Research
4.2 Global RNA Oligonucleotide Synthesis Service Sales Value by Application
4.2.1 Global RNA Oligonucleotide Synthesis Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global RNA Oligonucleotide Synthesis Service Sales Value, by Application (2019-2030)
4.2.3 Global RNA Oligonucleotide Synthesis Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global RNA Oligonucleotide Synthesis Service Sales Value by Region
5.1.1 Global RNA Oligonucleotide Synthesis Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global RNA Oligonucleotide Synthesis Service Sales Value by Region (2019-2024)
5.1.3 Global RNA Oligonucleotide Synthesis Service Sales Value by Region (2025-2030)
5.1.4 Global RNA Oligonucleotide Synthesis Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
5.2.2 North America RNA Oligonucleotide Synthesis Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
5.3.2 Europe RNA Oligonucleotide Synthesis Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
5.4.2 Asia Pacific RNA Oligonucleotide Synthesis Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
5.5.2 South America RNA Oligonucleotide Synthesis Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
5.6.2 Middle East & Africa RNA Oligonucleotide Synthesis Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions RNA Oligonucleotide Synthesis Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions RNA Oligonucleotide Synthesis Service Sales Value
6.3 United States
6.3.1 United States RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
6.3.2 United States RNA Oligonucleotide Synthesis Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States RNA Oligonucleotide Synthesis Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
6.4.2 Europe RNA Oligonucleotide Synthesis Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe RNA Oligonucleotide Synthesis Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
6.5.2 China RNA Oligonucleotide Synthesis Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China RNA Oligonucleotide Synthesis Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
6.6.2 Japan RNA Oligonucleotide Synthesis Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan RNA Oligonucleotide Synthesis Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
6.7.2 South Korea RNA Oligonucleotide Synthesis Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea RNA Oligonucleotide Synthesis Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
6.8.2 Southeast Asia RNA Oligonucleotide Synthesis Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia RNA Oligonucleotide Synthesis Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India RNA Oligonucleotide Synthesis Service Sales Value, 2019-2030
6.9.2 India RNA Oligonucleotide Synthesis Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India RNA Oligonucleotide Synthesis Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GenScript
7.1.1 GenScript Profile
7.1.2 GenScript Main Business
7.1.3 GenScript RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.1.4 GenScript RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.1.5 GenScript Recent Developments
7.2 OriGene
7.2.1 OriGene Profile
7.2.2 OriGene Main Business
7.2.3 OriGene RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.2.4 OriGene RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.2.5 OriGene Recent Developments
7.3 BBI
7.3.1 BBI Profile
7.3.2 BBI Main Business
7.3.3 BBI RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.3.4 BBI RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.3.5 Genewiz Recent Developments
7.4 Genewiz
7.4.1 Genewiz Profile
7.4.2 Genewiz Main Business
7.4.3 Genewiz RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.4.4 Genewiz RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.4.5 Genewiz Recent Developments
7.5 Eurofins Genomics
7.5.1 Eurofins Genomics Profile
7.5.2 Eurofins Genomics Main Business
7.5.3 Eurofins Genomics RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.5.4 Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.5.5 Eurofins Genomics Recent Developments
7.6 Gene Oracle
7.6.1 Gene Oracle Profile
7.6.2 Gene Oracle Main Business
7.6.3 Gene Oracle RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.6.4 Gene Oracle RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.6.5 Gene Oracle Recent Developments
7.7 SBS Genetech
7.7.1 SBS Genetech Profile
7.7.2 SBS Genetech Main Business
7.7.3 SBS Genetech RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.7.4 SBS Genetech RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.7.5 SBS Genetech Recent Developments
7.8 Creative Biolabs
7.8.1 Creative Biolabs Profile
7.8.2 Creative Biolabs Main Business
7.8.3 Creative Biolabs RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.8.4 Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.8.5 Creative Biolabs Recent Developments
7.9 Bio Basic
7.9.1 Bio Basic Profile
7.9.2 Bio Basic Main Business
7.9.3 Bio Basic RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.9.4 Bio Basic RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.9.5 Bio Basic Recent Developments
7.10 Kaneka Eurogentec SA
7.10.1 Kaneka Eurogentec SA Profile
7.10.2 Kaneka Eurogentec SA Main Business
7.10.3 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.10.4 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.10.5 Kaneka Eurogentec SA Recent Developments
7.11 AltaBioscience
7.11.1 AltaBioscience Profile
7.11.2 AltaBioscience Main Business
7.11.3 AltaBioscience RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.11.4 AltaBioscience RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.11.5 AltaBioscience Recent Developments
7.12 Synbio Technologies
7.12.1 Synbio Technologies Profile
7.12.2 Synbio Technologies Main Business
7.12.3 Synbio Technologies RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.12.4 Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.12.5 Synbio Technologies Recent Developments
7.13 TriLink
7.13.1 TriLink Profile
7.13.2 TriLink Main Business
7.13.3 TriLink RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.13.4 TriLink RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.13.5 TriLink Recent Developments
7.14 Azenta Life Science
7.14.1 Azenta Life Science Profile
7.14.2 Azenta Life Science Main Business
7.14.3 Azenta Life Science RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.14.4 Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.14.5 Azenta Life Science Recent Developments
7.15 KareBay Biochem
7.15.1 KareBay Biochem Profile
7.15.2 KareBay Biochem Main Business
7.15.3 KareBay Biochem RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.15.4 KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.15.5 KareBay Biochem Recent Developments
7.16 Creative Biogene
7.16.1 Creative Biogene Profile
7.16.2 Creative Biogene Main Business
7.16.3 Creative Biogene RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.16.4 Creative Biogene RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.16.5 Creative Biogene Recent Developments
7.17 Generi Biotech
7.17.1 Generi Biotech Profile
7.17.2 Generi Biotech Main Business
7.17.3 Generi Biotech RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.17.4 Generi Biotech RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.17.5 Generi Biotech Recent Developments
7.18 Primetech
7.18.1 Primetech Profile
7.18.2 Primetech Main Business
7.18.3 Primetech RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.18.4 Primetech RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.18.5 Primetech Recent Developments
7.19 General Biosystems
7.19.1 General Biosystems Profile
7.19.2 General Biosystems Main Business
7.19.3 General Biosystems RNA Oligonucleotide Synthesis Service Products, Services and Solutions
7.19.4 General Biosystems RNA Oligonucleotide Synthesis Service Revenue (US$ Million) & (2019-2024)
7.19.5 General Biosystems Recent Developments
8 Industry Chain Analysis
8.1 RNA Oligonucleotide Synthesis Service Industrial Chain
8.2 RNA Oligonucleotide Synthesis Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 RNA Oligonucleotide Synthesis Service Sales Model
8.5.2 Sales Channel
8.5.3 RNA Oligonucleotide Synthesis Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

GenScript
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.